The ability of HCLK2/Tel2 to transmit the initial activation of DNA damage from ATR to the telomere provides a hypothetical common mechanism that may underlie oncogenic signaling in both familial cancer syndromes such as Fanconi’s anemia and sporadic cancers. Here, TELO2 is linked to Fanconi anemia.